Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria-Reference-Cited by-同舟云学术

Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria

Published:2018-04-11 Issue:3 Volume:104 Page:148-156
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori

Author:

Alongi Filippo¹²,Mazzola Rosario¹,Figlia Vanessa¹,Guckenberger Matthias³

Affiliation:

1. Radiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy

2. University of Brescia, Brescia, Italy

3. Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland

Abstract

Exhaustive criteria and definitive data to identify the ideal lung oligometastatic patient as a candidate for stereotactic body radiotherapy (SBRT) are lacking. Three distinct cohorts of oligometastatic patients could be distinguished: (1) patients with upfront diagnosis of oligometastases (synchronous or metachronous); (2) patients with oligorecurrent disease in terms of relapsed oligometastatic phase; (3) oligoprogressive patients after cytoreductive treatment. The aim of the present review is to analyze available data concerning the efficacy/safety of SBRT for oligometastatic/oligoprogressive/oligorecurrent lung metastases.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0300891618766820

Reference30 articles.

1. Oligometastases.

2. Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases

3. Oligoprogression

4. Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer

5. Formulating a researchable question: A critical step for facilitating good clinical research

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression;Diagnostics;2023-04-29

2. A critical review on oligometastatic disease: a radiation oncologist’s perspective;Medical Oncology;2022-09-07

3. Lung metastases radiation therapy;Cancer/Radiothérapie;2022-02

4. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis;Clinical & Experimental Metastasis;2021-10-15

5. The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC;Clinical Lung Cancer;2021-09